116 related articles for article (PubMed ID: 15823113)
1. Adjuvant radiotherapy in carcinomas of the uterine cervix: the prognostic value of hemoglobin levels.
Münstedt K; Johnson P; Bohlmann MK; Zygmunt M; von Georgi R; Vahrson H
Int J Gynecol Cancer; 2005; 15(2):285-91. PubMed ID: 15823113
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of anemia for patients with cervical cancer treated with irradiation].
Grigiene R; Aleknavicius E; Kurtinaitis J
Medicina (Kaunas); 2005; 41(11):916-24. PubMed ID: 16333214
[TBL] [Abstract][Full Text] [Related]
3. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
4. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
[TBL] [Abstract][Full Text] [Related]
5. Consequences of inadvertent, suboptimal primary surgery in carcinoma of the uterine cervix.
Münstedt K; Johnson P; von Georgi R; Vahrson H; Tinneberg HR
Gynecol Oncol; 2004 Aug; 94(2):515-20. PubMed ID: 15297197
[TBL] [Abstract][Full Text] [Related]
6. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
7. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
8. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
10. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of clusterin expression in advanced-stage cervical cancer treated with curative intended radiotherapy.
Watari H; Kinoshita R; Han Y; Wang L; Hosaka M; Taguchi H; Tsuchiya K; Tanaka S; Shirato H; Sakuragi N
Int J Gynecol Cancer; 2012 Mar; 22(3):465-70. PubMed ID: 21633299
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
[TBL] [Abstract][Full Text] [Related]
14. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
Doll KM; Donnelly E; Helenowski I; Rosenbloom L; Small W; Schink JC; Lurain JR
Am J Clin Oncol; 2014 Feb; 37(1):30-4. PubMed ID: 22992622
[TBL] [Abstract][Full Text] [Related]
15. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
[TBL] [Abstract][Full Text] [Related]
16. Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging.
Choi YS; Yi CM; Sin JI; Ye GW; Shin IH; Lee TS
Int J Gynecol Cancer; 2006; 16(5):1846-54. PubMed ID: 17009981
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
18. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
19. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
Distefano M; Ferrandina G; Smaniotto D; Margariti AP; Zannoni G; Macchia G; Manfredi R; Mangiacotti MG; Cellini N; Scambia G
Oncology; 2004; 67(2):103-11. PubMed ID: 15539913
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]